STOCK TITAN

ARKEMA S/ADR - ARKAY STOCK NEWS

Welcome to our dedicated page for ARKEMA S/ADR news (Ticker: ARKAY), a resource for investors and traders seeking the latest updates and insights on ARKEMA S/ADR stock.

ARKEMA S/ADR, traded under the symbol ARKAY, is a global leader in specialty chemicals and advanced materials, serving industries such as transportation, construction, packaging, electronics, and more. With a focus on innovation, sustainability, and customer satisfaction, ARKEMA offers a diverse product portfolio that includes polymers, performance additives, adhesives, coatings, and more. The company has a strong presence worldwide, with numerous manufacturing sites and research centers dedicated to developing cutting-edge solutions for various applications. ARKEMA's commitment to excellence and continuous improvement drives its success in delivering high-quality products and services to meet the evolving needs of its customers.

Rhea-AI Summary
Livent Corporation (LTHM) announced the virtual Livent Special Meeting on December 19, 2023, to vote on the proposed merger with Allkem Limited (AKE). The Livent Board recommends voting 'FOR' the merger. The registration statement on Form S-4 of Arcadium Lithium plc has become effective, serving as a proxy statement and prospectus. Livent stockholders needing assistance can contact Morrow Sodali, LLC. The closing of the Transaction is targeted for January 4, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
-
Rhea-AI Summary

Arkema invites shareholders to its annual general meeting on May 11, 2023, at 10 a.m. Paris time, at Maison de la Mutualité, Paris. Key documents, including the preliminary notice, are available on Arkema's website. The company reported sales of approximately €11.5 billion in 2022 and aims to be a pure player in Specialty Materials by 2024, with a focus on Adhesive Solutions, Advanced Materials, and Coating Solutions. These segments collectively contributed 91% to Group sales last year. The meeting will address the company's performance and future strategy as Arkema positions itself to meet growing demands for sustainable materials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
-
Rhea-AI Summary

Arkema has announced share buyback transactions conducted from April 10 to April 14, 2023, in compliance with regulatory standards. A total of 22,000 shares were repurchased at an average price of 89.3916. The transactions included daily acquisitions of shares, detailing specific volumes and prices for each day. This move is part of Arkema's broader capital management strategy aimed at enhancing shareholder value. Investors can find further information on Arkema's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
none
Rhea-AI Summary

COLOMBES, France -- Arkema announces its share buyback transactions conducted from April 3 to April 6, 2023. The transactions were performed in compliance with Article 5 §2 of Regulation (EU) No 596/2014. During this period, Arkema purchased a total of 28,000 shares at a weighted average price of €89.5282 per share. Each day of transactions included consistent buybacks of 7,000 shares, with prices ranging from €87.9428 to €91.3583. Details about the transactions and their compliance with regulations are available on the Arkema investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.64%
Tags
none
-
Rhea-AI Summary

Arkema, listed on Euronext Paris under ticker AKE, reported key shareholding metrics as of March 31, 2023. The total number of shares stood at 75,043,514. The total number of voting rights, including shares held by the company, was 92,909,640, while the total voting rights, excluding shares held by the company, was 92,620,877. These figures provide insight into the company's current capital structure and shareholder engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Arkema, listed on Euronext Paris under the symbol AKE, published its 2022 Universal Registration Document on 28 March 2023. This comprehensive document, available for free to the public, contains crucial information including the 2022 Annual Financial Report, Board of Director’s Management Report, Corporate Governance Report, and detailed financial statements. It outlines the agenda for the combined annual general meeting scheduled for 11 May 2023 and includes insights on the share buyback program and Statutory Auditor’s Reports. Stakeholders can access the document on both Arkema's website and the French Financial Markets Authority's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
Rhea-AI Summary

Arkema has announced share buyback transactions conducted from March 6 to March 10, 2023. A total of 29,000 shares were repurchased during this period at a weighted average price of €97.3854 per share. The individual daily transactions included 7,000 shares bought on each day from March 6 to March 9 and 1,000 shares on March 10. These buybacks are part of Arkema's strategy to manage capital and return value to shareholders. The detailed transaction information is also accessible on Arkema's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
none
-
Rhea-AI Summary

On February 28, 2023, Arkema reported its total share count and voting rights in a regulatory announcement. The company has a total of 75,043,514 shares and 92,915,188 voting rights, including shares held by the company. Excluding treasury shares, the total number of voting rights stands at 92,676,425. This regulatory update is crucial for stakeholders observing the company's governance and share distribution metrics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
Rhea-AI Summary

Arkema, traded on Euronext Paris under the ticker AKE, announced its share buyback activities conducted from March 1 to March 3, 2023. A total of 21,000 shares were repurchased at a weighted average price of €96.9960 per share. Details of the transactions were disclosed in compliance with Regulation (EU) No 596/2014, reflecting the company's ongoing commitment to enhancing shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

On February 22, 2023, Arkema's Board of Directors proposed the renewal of Hélène Moreau-Leroy and Ian Hudson as directors, and appointed Florence Lambert and Séverin Cabannes to the Board during the upcoming shareholders’ meeting on May 11, 2023. The renewals aim to leverage Moreau-Leroy's and Hudson's extensive experience in industrial sectors and specialty chemicals, respectively. Lambert brings expertise in energy transition and innovation, while Cabannes contributes financial acumen from his banking background. The Board expressed gratitude towards outgoing directors Victoire de Margerie and Laurent Mignon for their contributions. Governance changes will be detailed in the 2022 Universal Registration Document, set to release on March 28, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
management

FAQ

What is the current stock price of ARKEMA S/ADR (ARKAY)?

The current stock price of ARKEMA S/ADR (ARKAY) is $106 as of May 20, 2024.

What is the market cap of ARKEMA S/ADR (ARKAY)?

The market cap of ARKEMA S/ADR (ARKAY) is approximately 7.8B.

What industries does ARKEMA serve?

ARKEMA serves industries such as transportation, construction, packaging, electronics, and more with its specialty chemicals and advanced materials.

What products does ARKEMA offer?

ARKEMA offers a diverse product portfolio including polymers, performance additives, adhesives, coatings, and more.

Where is ARKEMA headquartered?

ARKEMA is a global company with its headquarters located in France.

What is ARKEMA's focus?

ARKEMA focuses on innovation, sustainability, customer satisfaction, and continuous improvement in delivering high-quality solutions.

How does ARKEMA contribute to sustainability?

ARKEMA is committed to sustainability and develops environmentally friendly products and processes to minimize its impact on the environment.

What is ARKEMA's global presence?

ARKEMA has a strong global presence with manufacturing sites and research centers worldwide dedicated to developing cutting-edge solutions.

What drives ARKEMA's success?

ARKEMA's commitment to excellence, innovation, and customer satisfaction drives its success in meeting the evolving needs of its customers.

What are some key highlights of ARKEMA's operations?

ARKEMA's operations focus on providing high-quality specialty chemicals and advanced materials to various industries, with a strong emphasis on innovation and sustainability.

How does ARKEMA ensure product quality?

ARKEMA ensures product quality through rigorous testing, quality control processes, and adherence to industry standards.

What sets ARKEMA apart from competitors?

ARKEMA's dedication to innovation, sustainability, and customer-centric approach sets it apart from competitors in the specialty chemicals and advanced materials industry.
ARKEMA S/ADR

NYSE:ARKAY

ARKAY Rankings

ARKAY Stock Data

7.78B
74.63M
0.01%
Specialty Chemicals
Basic Materials
Link
United States of America
Colombes